Decibel Therapeutics, Inc. Financing Cash Flow
Decibel Therapeutics, Inc. reported Financing Cash Flow of $403.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2023-08-11
- Decibel Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2023-06-30 was $206.00K.
- Decibel Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2023-03-31 was $197.00K.
- Decibel Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-12-31 was -$55.00K, a 136.42% decline year-over-year.
- Decibel Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-09-30 was -$54.00K, a 205.88% decline year-over-year.
- Decibel Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2022 was -$213.00K, a 100.14% decline from fiscal 2021.
- Decibel Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $152.51M, a 178.03% increase from fiscal 2020.
- Decibel Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2020 was $54.85M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2023-06-30 | $206.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $403.00K 10-Q · filed 2023-08-11 | $348.00K derived: sum of 3 quarters · filed 2023-08-11 | $294.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2023-03-31 | $197.00K 10-Q · filed 2023-05-15 | $142.00K derived: sum of 2 quarters · filed 2023-05-15 | $88.00K derived: sum of 3 quarters · filed 2023-05-15 | $36.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-12-31 | -$55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$109.00K derived: sum of 2 quarters · filed 2023-03-14 | -$161.00K derived: sum of 3 quarters · filed 2023-08-11 | -$213.00K 10-K · filed 2023-03-14 |
| 2022-09-30 | -$54.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$106.00K derived: sum of 2 quarters · filed 2023-08-11 | -$158.00K 10-Q · filed 2022-11-09 | -$7.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-06-30 | -$52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$104.00K 10-Q · filed 2023-08-11 | $47.00K derived: sum of 3 quarters · filed 2023-08-11 | $98.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$52.00K 10-Q · filed 2023-05-15 | $99.00K derived: sum of 2 quarters · filed 2023-05-15 | $150.00K derived: sum of 3 quarters · filed 2023-05-15 | -$690.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $202.00K derived: sum of 2 quarters · filed 2023-03-14 | -$638.00K derived: sum of 3 quarters · filed 2023-03-14 | $152.51M 10-K · filed 2023-03-14 |
| 2021-09-30 | $51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$789.00K derived: sum of 2 quarters · filed 2022-11-09 | $152.36M 10-Q · filed 2022-11-09 | $206.75M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$840.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $152.31M 10-Q · filed 2022-08-10 | $206.69M derived: sum of 3 quarters · filed 2022-08-10 | |
| 2021-03-31 | $153.15M 10-Q · filed 2022-05-12 | $207.53M derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $54.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $54.85M 10-K · filed 2022-03-18 | ||
| 2020-09-30 | $466.00K 10-Q · filed 2021-11-10 |